Clinical Trial Update: Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of gemcitabine, 5-fluorouracil, and radiation therapy for non-metastatic pancreatic cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Gemzar (gemcitabine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pancreatic Cancer | Phase 1 | Status: COMPLETED